Important note: Information in this article was accurate in 1985. The state of the art may have changed since the publication date.
Tuberculosis, atypical mycobacteriosis, and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in south Florida.
Ann Intern Med. 1984 Nov;101(5):641-5. Unique Identifier : AIDSLINE MED/85020955 Pitchenik AE; Cole C; Russell BW; Fischl MA; Spira TJ; Snider DE Jr
Abstract:
To study the association between mycobacterial disease and the acquired immunodeficiency syndrome, we reviewed the records of all cases of tuberculosis and all cases of the syndrome reported in Dade County, Florida, from January 1980 through June 1983. Tuberculosis was diagnosed in 27 of 45 Haitians with the syndrome, but in only 1 of 37 non-Haitians with the syndrome (p less than 0.001). Among the 27 Haitians with the syndrome and tuberculosis, 19 had extrapulmonary tuberculosis, whereas among 286 Haitian patients with tuberculosis without the syndrome, only 56 had extrapulmonary tuberculosis (p less than 0.001). Tuberculosis preceded the syndrome by 1 to 17 months (mean, 6) in 22 patients. In 10 patients with the syndrome and positive sputum cultures who were treated with conventional antituberculosis drugs, the cultures became negative within 1 to 4 months and tuberculosis did not recur. The frequency of disseminated atypical mycobacteriosis or positive sputum cultures for atypical mycobacteria was not significantly different between Haitian (11.3%) and non-Haitian (8.3%) patients with the syndrome.
Keywords: Acquired Immunodeficiency Syndrome/COMPLICATIONS/*EPIDEMIOLOGY Adult Antitubercular Agents/THERAPEUTIC USE Aspartate Aminotransferase/BLOOD Blacks Cuba/ETHNOLOGY Florida Haiti/ETHNOLOGY Human Middle Age Mycobacterium Infections/*EPIDEMIOLOGY Mycobacterium Infections, Atypical/COMPLICATIONS/DRUG THERAPY/ *EPIDEMIOLOGY Pneumonia, Pneumocystis carinii/EPIDEMIOLOGY Sarcoma, Kaposi's/EPIDEMIOLOGY Support, Non-U.S. Gov't Tuberculosis/COMPLICATIONS/DRUG THERAPY/*EPIDEMIOLOGY Tuberculosis, Pulmonary/EPIDEMIOLOGY Whites JOURNAL ARTICLE
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1985. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Important note: Information in this article was accurate in 1985. The state of the art may have changed since the publication date.
